Technical Analysis for ADIL - Adial Pharmaceuticals, Inc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 1.63 | 3.16% | 0.05 |
ADIL closed up 3.16 percent on Monday, March 18, 2024, on 7 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Mar 28
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Fell Below 20 DMA | Bearish | 3.16% | |
Wide Bands | Range Expansion | 3.16% | |
Down 3 Days in a Row | Weakness | 3.16% | |
Down 4 Days in a Row | Weakness | 3.16% | |
Down 5 Days in a Row | Weakness | 3.16% | |
20 DMA Support | Bullish | -6.32% |
Alert | Time |
---|---|
Possible NR7 | about 12 hours ago |
Possible Inside Day | about 12 hours ago |
20 DMA Resistance | about 13 hours ago |
60 Minute Opening Range Breakout | about 16 hours ago |
Up 5% | about 16 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/28/2024
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of a therapeutic agent for the treatment of alcohol use disorder (AUD). Its lead drug product is AD04. AD04 is a selective serotonin-3 antagonist. AD04 can also be used for the treatment of other addictive disorders, such as obesity, smoking, and drug addiction. The Company has completed a Phase-II clinical trials of AD04.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Alcohol Medication Mental Health Obesity Psychiatry Smoking Drug Products Addiction
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Alcohol Medication Mental Health Obesity Psychiatry Smoking Drug Products Addiction
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 14.0 |
52 Week Low | 0.765 |
Average Volume | 4,860,561 |
200-Day Moving Average | 3.22 |
50-Day Moving Average | 1.48 |
20-Day Moving Average | 1.73 |
10-Day Moving Average | 1.97 |
Average True Range | 0.43 |
RSI (14) | 48.19 |
ADX | 41.67 |
+DI | 30.25 |
-DI | 16.12 |
Chandelier Exit (Long, 3 ATRs) | 2.88 |
Chandelier Exit (Short, 3 ATRs) | 2.05 |
Upper Bollinger Bands | 3.11 |
Lower Bollinger Band | 0.36 |
Percent B (%b) | 0.46 |
BandWidth | 158.53 |
MACD Line | 0.11 |
MACD Signal Line | 0.17 |
MACD Histogram | -0.0628 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.95 | ||||
Resistance 3 (R3) | 1.95 | 1.85 | 1.89 | ||
Resistance 2 (R2) | 1.85 | 1.77 | 1.85 | 1.87 | |
Resistance 1 (R1) | 1.74 | 1.72 | 1.80 | 1.74 | 1.86 |
Pivot Point | 1.64 | 1.64 | 1.67 | 1.64 | 1.64 |
Support 1 (S1) | 1.53 | 1.56 | 1.59 | 1.53 | 1.40 |
Support 2 (S2) | 1.43 | 1.51 | 1.43 | 1.39 | |
Support 3 (S3) | 1.32 | 1.43 | 1.37 | ||
Support 4 (S4) | 1.32 |